Ferronova secures A$11 million to advance nanotech image-guided cancer therapy
ADELAIDE, Australia, Jan. 23, 2023 /PRNewswire/ -- Australian biotech company Ferronova announced today it has secured a further A$11 million to progress the company's nanoparticle platform to assist surgeons to more accurately locate and remove malignant cells during treatment of gastrointestinal and brain tumors. Irish company Renew Pharmaceuticals Limited (Renew) led an A$8 million capital raise, with a further A$3 million secured via an Australian Government Co-operative Research Centers Project (CRC-P)grant.* Existing Ferronova shareholders, led by Uniseed with Artesian Venture Partne...
Source: philippinetimes.com